V. A. Silva

Decreased Neurofilament L Chain Levels in Cerebrospinal Fluid and Tolerogenic Plasmacytoid Dendritic Cells in Natalizumab-Treated Multiple Sclerosis Patients – Brief Research Report

A. Damasceno, C. O. Brandão, R. Domingues, 2021, Frontiers in Cellular Neuroscience.

Dimethyl fumarate downregulates the immune response through the HCA2/GPR109A pathway: Implications for the treatment of multiple sclerosis.

C. Baecher-Allan, A. Farias, Leonilda M. B. Santos, 2018, Multiple sclerosis and related disorders.